Erythropoietin treatments may increase hip fracture risk in patients with kidney failure
Erythropoietin (EPO) is a medication used to stimulate the production of new red blood cells, which is impaired in individuals with kidney failure. Unfortunately, however, the treatment may increase the risk of hip fractures.
May 5, 2021
0
3